| 영문 | vaccine | 한글 | 백신 |
|---|---|---|---|
| 설명 | 전염병에 대하여 인공적으로 면역을 주기 위해 생체에 투여하는 항원의 하나. 병원체 및 독소에 대한 방어기구를 강화할 목적으로 사용되는 미생물제제를 말한다. 프랑스의 미생물학자 L. 파스퇴르에 의하여 제창된 용어로서, 어떤 감염증에 대하여 인공적으로 면역을 얻기 위하여 그 병원 미생물 또는 그 독소액에 적당한 조작을 가하여 만든 것을 말한다. |
||
| 영문 | malignant melanoma | 한글 | 악성흑색종 |
|---|---|---|---|
| 설명 | 피부에서 생기는 암의 일종. 주로 백인에게 호발하며, 50대~70대에 많이 발생하고, 젊은 여성에게 증가하는 경향이 있으며, 피부암중 1~3%를 차지하는 드문 병으로 피부와 기타 기관의 멜라닌 세포계에서 유래하는 악성종양이다. 원인으로 일광노출과 직접적인 관계가 있으며 가족적 발생도 볼 수 있다. |
||
| MM | macromolecule; Maelzels metronome; major medical [insurance]; malignant melanoma; manubrium to malle... |
|---|---|
| ABCD | airway, breathing, circulation, differential diagnosis (or defibrillate) [in cardiopulmonary resusci... |
| ALM | aerial lentiginous melanoma; alveolar living material |
| CMM | cell-mediated mutagenesis; cutaneous malignant melanoma |
| FAMMM | familial atypical multiple mole-melanoma [syndrome] |
| BPV | Bordatella pertussis vaccine |
|---|---|
| DTP | Diphtheria-tetanus-pertussis vaccine |
| Hib | Haemophilus influenzae type b vaccine |
| HDCV | Human Diploid Cell Vaccine |
| IPV | Inactivated Polio-Vaccine |
| acral lentiginous melanoma | <tumour> A form of malignant lentigo melanoma that occurs in acral areas not excessively exposed to sunlight and where hair follicles are absent. (05 Mar 2000) |
|---|---|
| amelanotic melanoma | <tumour> An anaplastic melanoma consisting of cells derived from melanocytes but not forming melanin. (05 Mar 2000) |
| benign juvenile melanoma | A benign, slightly pigmented or red superficial small skin tumour composed of spindle-shaped, epithelioid, and multinucleated cells that may appear atypical; most common in children, but also appearing in adults. Synonym: benign juvenile melanoma, epithelioid cell nevus, spindle cell nevus. (05 Mar 2000) |
| cancer, malignant melanoma | A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. Melanoma can be cured if detected early, before spread (metastasis) to other areas of the body. Diagnosis is confirmed with a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma. (12 Dec 1998) |
| cancer, melanoma | A skin cancer that begins in cells called melanocytes that can grow together to form benign (not cancerous) moles. A change in size, shape, or colour of a mole can be a sign of melanoma. It can be cured if detected early, before spread (metastasis) to other areas. Diagnosis is confirmed by a biopsy of the abnormal skin. Sun exposure can cause skin damage that can lead to melanoma. (12 Dec 1998) |
| malignant lentigo melanoma | <tumour> A melanoma arising from a malignant lentigo. (05 Mar 2000) |
| malignant melanoma | <oncology, tumour> A malignant tumour which arises from the pigment producing cells (melanosomes) of the deeper layers of the skin (or the eye). Melanoma is the leading cause of death attributable to skin lesions. Described as an irregular dark skin lesion that may have areas of varying colour. Often greater than 6 mm in diameter. (27 Sep 1997) |
| malignant melanoma: gallium imaging | <radiology> Greater than50% sensitivity for primary and metastatic sites: 73% sensitivity if lesion is greater than 2 cm, 17% sensitivity if less than 2 cm, see: gallium: indications malignant melanoma (12 Dec 1998) |
| malignant melanoma in situ | A melanoma limited to the epidermis and composed of nests of atypical melanocytes and scattered single cells extending into the upper epidermis; local excision is curative although the lesion, if untreated, may soon invade the dermis. Malignant lentigo may be considered a slowly progressive type of malignant melanoma in situ. (05 Mar 2000) |
| malignant melanoma: staging | <radiology> Clark staging: level I: all tumour cells above basement membrane (in situ), level II: tumour extends to papillary dermis, level III: tumour extends to interface between papillary and reticular dermis, level IV: tumour extends between bundles of collagen of reticular dermis, level V: tumour invasion of sucutaneous tissue (87% metastases) Breslow staging: thin: less than 0.75 mm depth of invasion, intermediate: 0.76 - 3.99 mm depth of invasion, thick: greater than 4 mm depth of invasion see: malignant melanoma (12 Dec 1998) |
| melanoma | <oncology, tumour> A tumour arising from the melanocytic system of the skin and other organs. When used alone the term refers to malignant melanoma. (18 Nov 1997) |
| melanoma, amelanotic | An unpigmented malignant melanoma. It is an anaplastic melanoma consisting of cells derived from melanoblasts but not forming melanin. (12 Dec 1998) |
| melanoma growth stimulatory activity | Cytokine of the C X C subfamily. Potent mitogen. Activates and is chemotactic for, neutrophils. (18 Nov 1997) |
| minimal deviation melanoma | <dermatology, tumour> A malignant melanoma showing less cytologic atypia than is usual in melanoma cells showing asymmetric expansile invasion of the dermis. (05 Mar 2000) |
| Cloudman melanoma | <tumour> A transplantable melanoma that arose spontaneously in a mouse of DBA strain, and which grows and metastasizes in mice of related strains. (05 Mar 2000) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|